AddLife AB (publ) (STO:ALIF.B)

Market Cap	22.95B
Revenue (ttm)	10.42B
Net Income (ttm)	309.00M
Shares Out	121.86M
EPS (ttm)	2.53
PE Ratio	74.49
Forward PE	43.78
Dividend	0.75 (0.40%)
Ex-Dividend Date	May 9, 2025

Volume	93,907
Average Volume	214,468
Open	188.80
Previous Close	188.20
Day's Range	185.80 - 188.90
52-Week Range	105.80 - 193.00
Beta	1.65
RSI	73.99
Earnings Date	Jul 15, 2025

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1906
• Employees: 2,181
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ALIF.B

Financial Performance

In 2024, AddLife AB's revenue was 10.29 billion, an increase of 6.21% compared to the previous year's 9.69 billion. Earnings were 252.00 million, an increase of 32.63%.